阴道恶性肿瘤诊断与治疗指南(2021年版)

2021-06-25 中国抗癌协会妇科肿瘤专业委员会 中国癌症杂志, 2021, 31(6): 546-560.

阴道恶性肿瘤可分为原发性和继发性肿瘤。由于发病率低,国内外均缺乏大样本、前瞻性的研究,故尚无统一的诊治标准。阴道鳞癌和黑色素瘤多见于老年或绝经后妇女。近年来由于高危型人乳头瘤病毒(human papi

中文标题:

阴道恶性肿瘤诊断与治疗指南(2021年版)

发布日期:

2021-06-25

简要介绍:

阴道恶性肿瘤可分为原发性和继发性肿瘤。由于发病率低,国内外均缺乏大样本、前瞻性的研究,故尚无统一的诊治标准。阴道鳞癌和黑色素瘤多见于老年或绝经后妇女。近年来由于高危型人乳头瘤病毒(human papillomavirus,HPV)持续感染增多,年轻的阴道鳞癌患者也在逐渐增多。腺癌好发于青春期,内胚窦瘤和葡萄状肉瘤则好发于婴幼儿。继发性阴道恶性肿瘤多来自相邻器官恶性肿瘤的直接蔓延、浸润以及淋巴转移,来自远隔器官的血行转移较少。

 

相关资料下载:
[AttachmentFileName(sort=1, fileName=阴道恶性肿瘤诊断与治疗指南(2021年版).pdf)] GetToolGuiderByIdResponse(projectId=1, id=03f4f1c002126991, title=阴道恶性肿瘤诊断与治疗指南(2021年版), enTitle=, guiderFrom=中国癌症杂志, 2021, 31(6): 546-560., authorId=0, author=, summary=阴道恶性肿瘤可分为原发性和继发性肿瘤。由于发病率低,国内外均缺乏大样本、前瞻性的研究,故尚无统一的诊治标准。阴道鳞癌和黑色素瘤多见于老年或绝经后妇女。近年来由于高危型人乳头瘤病毒(human papi, cover=https://img.medsci.cn/2021711/1626015903369_2020535.jpg, journalId=0, articlesId=null, associationId=1526, associationName=中国抗癌协会妇科肿瘤专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jun 25 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>阴道恶性肿瘤可分为原发性和继发性肿瘤。由于发病率低,国内外均缺乏大样本、前瞻性的研究,故尚无统一的诊治标准。阴道鳞癌和黑色素瘤多见于老年或绝经后妇女。近年来由于高危型人乳头瘤病毒(human papillomavirus,HPV)持续感染增多,年轻的阴道鳞癌患者也在逐渐增多。腺癌好发于青春期,内胚窦瘤和葡萄状肉瘤则好发于婴幼儿。继发性阴道恶性肿瘤多来自相邻器官恶性肿瘤的直接蔓延、浸润以及淋巴转移,来自远隔器官的血行转移较少。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=113409, tagName=阴道肿瘤)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=36, categoryName=妇产科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3912, appHits=146, showAppHits=0, pcHits=405, showPcHits=3766, likes=2, shares=15, comments=4, approvalStatus=1, publishedTime=Sun Jul 11 23:16:31 CST 2021, publishedTimeString=2021-06-25, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Jul 11 23:05:13 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 11:48:02 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=阴道恶性肿瘤诊断与治疗指南(2021年版).pdf)])
阴道恶性肿瘤诊断与治疗指南(2021年版).pdf
下载请点击:
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1195312, encodeId=bac9119531274, content=学习中,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b87f2193926, createdName=户外阳光, createdTime=Sun Feb 20 11:11:28 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083113, encodeId=628610831139c, content=学习,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe416418341, createdName=ms9000002103890093, createdTime=Wed Dec 22 16:35:20 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017075, encodeId=17e0101e075e2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dac5559376, createdName=晚笑7, createdTime=Mon Sep 13 16:08:35 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001978, encodeId=f5d410019e8e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=白ju, createdTime=Fri Jul 23 12:45:56 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2022-02-20 户外阳光

    学习中,谢谢

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1195312, encodeId=bac9119531274, content=学习中,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b87f2193926, createdName=户外阳光, createdTime=Sun Feb 20 11:11:28 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083113, encodeId=628610831139c, content=学习,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe416418341, createdName=ms9000002103890093, createdTime=Wed Dec 22 16:35:20 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017075, encodeId=17e0101e075e2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dac5559376, createdName=晚笑7, createdTime=Mon Sep 13 16:08:35 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001978, encodeId=f5d410019e8e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=白ju, createdTime=Fri Jul 23 12:45:56 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-12-22 ms9000002103890093

    学习,受益匪浅

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1195312, encodeId=bac9119531274, content=学习中,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b87f2193926, createdName=户外阳光, createdTime=Sun Feb 20 11:11:28 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083113, encodeId=628610831139c, content=学习,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe416418341, createdName=ms9000002103890093, createdTime=Wed Dec 22 16:35:20 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017075, encodeId=17e0101e075e2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dac5559376, createdName=晚笑7, createdTime=Mon Sep 13 16:08:35 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001978, encodeId=f5d410019e8e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=白ju, createdTime=Fri Jul 23 12:45:56 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-09-13 晚笑7

    学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1195312, encodeId=bac9119531274, content=学习中,谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=b87f2193926, createdName=户外阳光, createdTime=Sun Feb 20 11:11:28 CST 2022, time=2022-02-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1083113, encodeId=628610831139c, content=学习,受益匪浅, beContent=null, objectType=guider, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fe416418341, createdName=ms9000002103890093, createdTime=Wed Dec 22 16:35:20 CST 2021, time=2021-12-22, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1017075, encodeId=17e0101e075e2, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=47, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7dac5559376, createdName=晚笑7, createdTime=Mon Sep 13 16:08:35 CST 2021, time=2021-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1001978, encodeId=f5d410019e8e8, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201009/850075858cc4481aa22c247c691bc9b6/4a0a2f141a844cb2a0af4d9ae3c281b1.jpg, createdBy=10bd2163613, createdName=白ju, createdTime=Fri Jul 23 12:45:56 CST 2021, time=2021-07-23, status=1, ipAttribution=)]
    2021-07-23 白ju

    学习

    0